Literature DB >> 11859057

Gastro-oesophageal reflux disease in general practice. Last year's guidelines are probably biased.

Helge L Waldum, Eiliv Brenna.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 11859057      PMCID: PMC1122401     

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  8 in total

Review 1.  Management of gastro-oesophageal reflux disease in general practice.

Authors:  J Dent; R Jones; P Kahrilas; N J Talley
Journal:  BMJ       Date:  2001-02-10

2.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

Review 3.  Blood, urine, stool, breath, money, and Helicobacter pylori.

Authors:  D Vaira; N Vakil
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

4.  Treating non-ulcer dyspepsia and H pylori.

Authors:  S J van Zanten
Journal:  BMJ       Date:  2000-09-16

Review 5.  Personal review: is profound acid inhibition safe?

Authors:  H L Waldum; E Brenna
Journal:  Aliment Pharmacol Ther       Date:  2000-01       Impact factor: 8.171

Review 6.  Personal review: alarmism or legitimate concerns about long-term suppression of gastric acid secretion?

Authors:  N D Yeomans; J Dent
Journal:  Aliment Pharmacol Ther       Date:  2000-03       Impact factor: 8.171

7.  Effect of population screening and treatment for Helicobacter pylori on dyspepsia and quality of life in the community: a randomised controlled trial. Leeds HELP Study Group.

Authors:  P Moayyedi; R Feltbower; J Brown; S Mason; J Mason; J Nathan; I D Richards; A C Dowell; A T Axon
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

Review 8.  Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.

Authors:  P Moayyedi; S Soo; J Deeks; D Forman; J Mason; M Innes; B Delaney
Journal:  BMJ       Date:  2000-09-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.